The earnestness and innocence of Guangdong's mass procurement reflects the new changes in centralized drug procurement!

Recently, the 281 catalogue of Guangdong Cross-regional and Inter-provincial Purchasing Alliance has attracted great attention from all walks of life in the pharmaceutical industry.
Some are gearing up, some are lost in heart, some are panicked, and some are screaming
.

The author has carefully read the rumors, combined with the Guangdong Provincial Group Procurement Draft issued by the government not long ago, and believes that from the second half of this year to 2022, the centralized drug procurement has shown a completely different change from the past

Since Guangdong is mentioned, let's make Guangdong clear first
.

The author always believes that in the next big game in Guangdong, Guangdong has been very serious about purchasing in quantity, but at the same time, it also has its "naive" side

1.
About being serious

Guangdong is very serious about volume procurement.
Other provinces will see 2022 at most, while Guangdong has formulated a 14th Five-Year Plan for volume procurement of drugs
.

There is no way, the plate is big, the foundation is good, there are conditions, ability, and level

At the beginning of the year, national leaders pointed out at the meeting that centralized drug procurement should reduce the burden on patients while taking into account the reasonable profits of the enterprise
.

Unsurprisingly, the country opened its doors to allow multiple selections

In the past, substantial price cuts were due to the fact that companies were unable to talk to the purchasing entities at the peak of falsely high prices.
This is why there are batches of precedents for the 50% drop at every turn.
However, the precedents did not make relevant companies become " "Martyrs", the idea of ​​eclecticism, quality improvement and innovation, and revenue and expenditure reduction are deeply rooted in the hearts of the people.
Many companies have learned how to live a hard life and plan carefully to live a better cost-effective life
.

Now that the company wants to understand, there is no need for the purchasing department to make a single cut.

       Saying that Guangdong is serious is not only reflected in the above-mentioned aspects.
According to rumors, the bidding rules of Guangdong's volume procurement will be divided into two groups of bids, A and B, and A group of two rounds of quotations
.

In the first round of quotation in Group A, as long as the company's quotation is not higher than the limit price and its own national lowest price, 70-80% of its own company's pre-purchasing volume can be obtained, and 1-2 companies may be eliminated

       In this regard, it can be seen that Guangdong is quite serious, fully combining the spirit of the country’s policy deployment on volume procurement, and fully considering the medical insurance departments and medical institutions’ ideas on drug procurement.
Of course, it also takes care of participating in market competition.
The company’s interests in Guangdong and Guangdong’s practice have given companies that have always regarded volume procurement as a scourge, and feel that the wind direction of volume procurement has changed in Guangdong.
For this point, the author believes that Guangdong is really serious and very serious.
Seriously, do things seriously, think carefully, and don't regard lower prices as the only criterion
.

       2.
About innocence

       While being serious, Guangdong has some innocence
.

You will have to drink three hundred cups in one drink, and dispel eternal sorrows with you

       After talking about Guangdong, let's look at the new changes in national centralized procurement triggered by Guangdong
.

       1.
Quantity

       Guangdong’s 281 basically means that the 600+ of the Nanning Club has reached the stage of large-scale promotion
.

In the past, 30-40 per province even completed the task, but from the perspective of the eight provinces, two regions, and the Guangdong Union, the provinces have gradually grasped their spirits

       2.
area

       There are rumors that there were 240 varieties that were not covered by centralized procurement, which accounted for 39%.
Among them, there were 130 chemical medicines, accounting for 26% of the large number of chemical medicines, and 19 biological preparations.
, Accounting for 73% of the large variety of biological preparations; 91 kinds of proprietary Chinese medicines, accounting for 85% of the large variety of proprietary Chinese medicines
.
This 600+ catalog (not 620 rendered by various media) is still locked on the basis of the 500 catalog
.
Rather than want to see which varieties are in the 600+ category, it is more practical to look at the procurement progress of related varieties in the 500 catalog
.

       In the past, proprietary Chinese medicines were able to take care of themselves, but now they don’t
.
At the Nanning meeting, it was proposed that there are 107 large-amount Chinese patent medicines, except for the 9 exclusive varieties during the medical insurance negotiation agreement period, and the other 98 Chinese patent medicines to encourage local exploration and collection
.
In terms of centralized procurement rules, based on the clinical experience of experts, comprehensive scores can be used to group according to the characteristics of similar functions and indications, same name and same prescription, same effect and same price, and similar raw materials
.
Many varieties of production are collected by bidding
.
Exclusively produced varieties can be combined for bidding, or negotiated and negotiated
.
In terms of variety selection, priority can be given to unilateral varieties with clear active ingredients, relatively clear indications, and produced by multiple companies
.
It is suggested that in 2021, all provinces should collect 5 varieties of Chinese patent medicines
.
The problem is that many provinces have already completed their tasks.
What about the plans for the five proprietary Chinese medicines? At present, since Guangdong has already taken over, the Chinese patent medicine is simply handed over to Guangdong
.
Therefore, Guangdong's 281 catalogue must pay close attention to and pay attention to the enterprises of proprietary Chinese medicines
.

       3.
Bargaining

       On January 28, Guocai Document No.
2 required to explore the merger of different generic drugs with similar indications or functions and indications to carry out centralized and high-volume procurement
.
At that time, the author understood that exploration is only one direction.
If you can do it, you can do it.
If you can't, you can continue to use the original plan without exploring
.
Sure enough, Nanning will announce that the 37 kinds of chemical medicines exclusively produced are mainly negotiated
.
The varieties exclusively produced by proprietary Chinese medicines can be auctioned together or negotiated
.
According to incomplete statistics, there are 81 varieties with one brand participating in the Guangdong catalog (exclusive and exclusive winning varieties), and 65 varieties with two brands participating (multiple selections)
.
Therefore, the industry has been talking about mergers and market competition, and there is a high probability that Guangdong will be a weather vane
.
If Guangdong does not merge this year and focuses on bargaining, then at least this year, this trend will not spread on a large scale
.

       On the whole, the author wants to make another immature judgment: Guangdong is still in batches with high probability! At least so far, the author understands this way
.
If divided into batches, the maturity of the variety will be quite high
.
If not divided into batches, 281 may become a hodgepodge
.

       As for local procurement with large quantities, the number of varieties will be rapidly expanded, the scope will be fully considered, and the merger is still on the way to explore
.

       But it is undeniable that Guangdong’s today is the province’s tomorrow.
Don’t doubt the normalization of volume procurement speed, but under the premise of full competition, the provinces will start to adjust their price review direction, and the big cut will no longer be the same.
The mainstream direction, comprehensive review and price adjustment based on double envelopes, will be the mainstream of centralized procurement
.

       This is centralized procurement, and the price will always come down when it is high
.
This is the market, and the price is always too low to be adjusted back
.
Procurement with quantity has always been a game
.
The general trend of price-for- quantity has not changed, and the general direction of purchasing with volume has not changed.
The reason is simple:

       ——Society is simple, but people are complicated
.